Ghent University Academic Bibliography

Journal Article
A1
open access

Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer

Yong Xi, Zhijie Zhao, Yundong Zhou, Chengliang Yin, Yuxin Li, Xiao Xu (UGent) , Wenyi Jin, Chengbin Lin, Kui Zhao, Junjie Kuang, et al.

(2026) CELL REPORTS MEDICINE. 7(1).

Add to list

Journal Article
A1
open access

Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy

Margarida Oliveira Coelho, Sofia Torres Quintas, Bruno Sarmento, Olivier De Wever (UGent) and Flávia Raquel Teixeira De Castro

(2025) JOURNAL OF CONTROLLED RELEASE. 381.

Add to list

Journal Article
A1
open access

VSIG4-expressing macrophages contribute to antiparasitic and antimetastatic responses in the peritoneal cavity

Els Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, Sam Ernst (UGent) , Pauline M. R. Bardet, Aarushi A. Caro, Mate Kiss, Neema Ahishakiye Jumapili, Romina Mora Barthelmess, Maida Zivalj, et al.

(2025) EUROPEAN JOURNAL OF IMMUNOLOGY. 55(5).

Add to list

Fibroblast activation protein on human natural killer cells : insights from natural killer cell activation and crosstalk with cancer-associated fibroblasts

Yentl Van Rymenant, Anke de Groot, Laura Dirkx, Emile Verhulst, Joni De Loose, Isabel Pintelon, Tias Verhezen, Jorrit De Waele, Sofie Thys (UGent) , Olivier De Wever (UGent) , et al.

(2025) JOURNAL OF LEUKOCYTE BIOLOGY. 117(7).

Add to list

Journal Article
A1
open access

Glioma : bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy

Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko (UGent) , Maria V. Vedunova and Dmitri Krysko (UGent)

(2024) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Miscellaneous

Targeting immunogenic cell death for glioma immunotherapy

Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko (UGent) , Maria V. Vedunova and Dmitri Krysko (UGent)

(2024) TRENDS IN CANCER. 10(1). p.8-11

Add to list

Journal Article
A1
open access

Glioblastoma-associated mesenchymal stem/stromal cells and cancer-associated fibroblasts : partners in crime?

Thibault Lootens (UGent) , Bart Roman (UGent) , Christian Stevens (UGent) , Olivier De Wever (UGent) and Robrecht Raedt (UGent)

(2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(4).

Add to list

Journal Article
A1
open access

Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases : clinical and translational outcomes

R. Sundar, D.K.A. Chia, J.J. Zhao, A.R.Y.B. Lee, G. Kim, H.L. Tan, A. Pang, A. Shabbir, Wouter Willaert (UGent) , H. Ma, et al.

(2024) ESMO OPEN. 9(9).

Add to list

Journal Article
A1
open access

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).

Add to list

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491

Academic Bibliography

Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer

Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy

VSIG4-expressing macrophages contribute to antiparasitic and antimetastatic responses in the peritoneal cavity

Fibroblast activation protein on human natural killer cells : insights from natural killer cell activation and crosstalk with cancer-associated fibroblasts

Glioma : bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy

Targeting immunogenic cell death for glioma immunotherapy

Glioblastoma-associated mesenchymal stem/stromal cells and cancer-associated fibroblasts : partners in crime?

Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases : clinical and translational outcomes

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Contents

Support

Contact